Cargando…
Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT)
This study aimed to evaluate the correlation between in-house and commercial binding-specific IgG antibodies and between in-house and commercial SARS-CoV-2 surrogate virus neutralization tests (sVNT). Samples from healthcare workers who received vaccines against SARS-CoV-2 were tested for RBD-specif...
Autores principales: | Winichakoon, Poramed, Wipasa, Jiraprapa, Chawansuntati, Kriangkrai, Salee, Parichat, Sudjaritruk, Tavitiya, Yasri, Saowaluck, khamwan, Chantana, Peerakam, Rungnapa, Dankai, Dararat, Chaiwarith, Romanee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806819/ https://www.ncbi.nlm.nih.gov/pubmed/36593231 http://dx.doi.org/10.1038/s41598-022-26202-1 |
Ejemplares similares
-
Comparison of Immunogenicity and Reactogenicity of Five Primary Series of COVID-19 Vaccine Regimens against Circulating SARS-CoV-2 Variants of Concern among Healthy Thai Populations
por: Sudjaritruk, Tavitiya, et al.
Publicado: (2023) -
Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine
por: Chaiwarith, Romanee, et al.
Publicado: (2023) -
Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 (AZD1222) vaccination in Chiang Mai, Thailand
por: Hongjaisee, Sayamon, et al.
Publicado: (2023) -
Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study
por: Narongkiatikhun, Phoom, et al.
Publicado: (2023) -
Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac(®) and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175
por: Narongkiatikhun, Phoom, et al.
Publicado: (2023)